Lilly continues test of HDL cholesterol drug, on panel's advice

July 27 (Reuters) - Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise "good" HDL cholesterol and lower "bad" LDL cholesterol, acting on the recommendation of a data monitoring committee.